Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) EBITDA (2022 - 2025)

Historic EBITDA for Cannabis Bioscience International Holdings (CBIH) over the last 7 years, with Q3 2025 value amounting to -$74784.0.

  • Cannabis Bioscience International Holdings' EBITDA rose 2338.02% to -$74784.0 in Q3 2025 from the same period last year, while for Aug 2025 it was -$398545.0, marking a year-over-year decrease of 440.74%. This contributed to the annual value of -$421365.0 for FY2025, which is 1332.44% up from last year.
  • According to the latest figures from Q3 2025, Cannabis Bioscience International Holdings' EBITDA is -$74784.0, which was up 2338.02% from -$134900.0 recorded in Q2 2025.
  • Cannabis Bioscience International Holdings' 5-year EBITDA high stood at -$29634.0 for Q2 2024, and its period low was -$284866.0 during Q1 2023.
  • In the last 4 years, Cannabis Bioscience International Holdings' EBITDA had a median value of -$132067.0 in 2025 and averaged -$141701.8.
  • As far as peak fluctuations go, Cannabis Bioscience International Holdings' EBITDA skyrocketed by 8922.0% in 2024, and later plummeted by 35522.04% in 2025.
  • Over the past 4 years, Cannabis Bioscience International Holdings' EBITDA (Quarter) stood at -$183608.0 in 2022, then surged by 48.53% to -$94512.0 in 2023, then skyrocketed by 36.91% to -$59627.0 in 2024, then dropped by 25.42% to -$74784.0 in 2025.
  • Its EBITDA stands at -$74784.0 for Q3 2025, versus -$134900.0 for Q2 2025 and -$129234.0 for Q1 2025.